Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Contact Dermatitis|February 13, 2024
Sensitization to textile dyes in Spain: Epidemiological situation (2019-2022)Carlos Pelayo Hernández Fernández, Leopoldo Borrego, Ana María Giménez Arnau, et al.
Acta Dermato-Venereologica|March 12, 2026
Cutaneous Leishmaniasis in Patients under Biologic Therapies: A Spanish CLINI-AEDV Multicentre StudyAndrea Ciudad, Ramón M Pujol, Fernándo Gallardo, et al.
The British Journal of Dermatology|October 17, 2023
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registryJuan José Lluch-Galcerá, Jose Manuel Carrascosa, Alicia González-Quesada, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma RegistryCristina Muniesa, Fernando Gallardo, Ignacio García-Doval, et al.
Contact Dermatitis|February 14, 2024
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?Maria Elena Gatica-Ortega, Maria Antonia Pastor-Nieto, Ana María Giménez-Arnau, et al.
Contact Dermatitis|October 12, 2024
Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023David Pesqué, Nidia Planella-Fontanillas, Leopoldo Borrego, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 19, 2025
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM RegistryMaría Olivares-Guerrero, Esteban Daudén, Josep Riera-Monroig, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 30, 2025
Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registryJuan José Lluch-Galcerá, José Manuel Carrascosa, Alicia González-Quesada, et al.
Pageof 5